Publication
Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome.
Journal Paper/Review - Jul 22, 2022
Janssen J J W M, Löwenberg Bob, Manz M, Biemond B J, Westerweel P E, Klein S K, Fehr M, Sinnige H A M, Efthymiou Anna, Legdeur M C J C, Pabst T, Gregor M, van der Poel M W M, Deeren Dries, Tick L W, Jongen-Lavrencic Mojca, van Obbergh F, Boersma R S, de Weerdt Okke, Chalandon Yves, Heim D, Spertini Olivier, van Sluis G, Graux Carlos, Stüssi G, van Norden Y, Ossenkoppele G J
Janssen, J J W M
1
0
Löwenberg, Bob
5
0
Manz, M
2
0
Biemond, B J
1
0
Westerweel, P E
1
0
Klein, S K
1
0
Fehr, M
8
0
Sinnige, H A M
1
0
Efthymiou, Anna
4
0
Legdeur, M C J C
1
0
Pabst, T
5
0
Gregor, M
2
0
van der Poel, M W M
1
0
Deeren, Dries
3
0
Tick, L W
1
0
Jongen-Lavrencic, Mojca
3
0
van Obbergh, F
1
0
Boersma, R S
1
0
de Weerdt, Okke
3
0
Chalandon, Yves
9
0